LENALIDOMIDE AND RITUXIMAB (ReRi) AS FRONT LINE THERAPY OF ELDERLY FRAIL PATIENTS WITH DIFFUSE LARGE B‐CELLS LYMPHOMA. FIRST PLANNED INTERIM ANALYSIS OF A PHASE II STUDY OF THE FONDAZIONE ITALIANA LINFOMI (FIL).

Authors :: Gini, G.
Tani, M.
Bassan, R.
Tucci, A.
Ballerini, F.
Sampaolo, M.
Merli, F.
Re, F.
Annibali, O.
Liberati, A.
Visco, C.
Arcari, A.
Storti, S.
Fabbri, A.
Musuraca, G.
Zilioli, V.
Cox, M.
Luminari, S.
Source :: Hematological Oncology; Jun2019 Supplement S1, Vol. 37, p427-428, 2p
Publication Year :: 2019

Subjects :: DIFFUSE large B-cell lymphomas
FRAIL elderly
B cells
RITUXIMAB
OLDER patients
LYMPHOMAS

Full Text Access

Tools